All four patients had had persistent severe staining of their clothing in both cold and hot weather; conservative treatment including frequent washing and aluminium chlorhydrate deodorants had failed. Their ages in order of presentation (duration of symptoms in parentheses) were 26 (11 years), 31 (6 years), 16 (3 months) and 14 years (4 years).
In the first two patients, where the smaller cryoprobe tip was used, slight excessive secretion with minimal staining of clothing persisted for 4-5 months, and this arose from the gaps between sites of application. A further treatment was given to all four axillae, and one required a third application. Three of these four axillae have been observed for a year since the last treatment and one for nine months. All have less than normal amount of sweating, and this has not tended to increase. No full-thickness skin loss nor subcutaneous cellulitis arose as a result of the treatment. The two patients on whom the larger cryoprobe tip was used had excellent results with only one treatment to each axilla (follow-up in one 14 and in the other 10 months). At two application sites in one of these patients (and at two in a furher patient under treatment) full-thickness skin loss about 10-15 mm in diameter occurred but soon healed. Late sequelae included depigmentation and almost complete depilation (a welcome side effect), but there was no noticeable change in skin contour or texture, and no sebaceous cysts have arisen.
Discussion
The results to date of cryosurgery for axillary hyperhidrosis have been encouraging. The 18-mm diameter cryoprobe tip seems to be much more effective than the smaller one used at first, though it did cause an occasional small area of necrosis.
The two patients treated with the larger cryoprobe tip required less medical and nursing time, had less local infection, and had less disturbance to their usual routine compared with excision. In our experience the final cosmetic result was better after cryosurgery than after excision. 
Cigarette smoking and cancer of bladder and lung
Cigarette smoking is an aetiological factor in malignant disease in the lung, bladder, kidney, and larynx.' Hence some patients might be expected to develop more than one of these tumours. This paper records a series of eight such cases. Between 40 and 50 patients with carcinoma of the bladder are seen each year by one radiotherapy firm, in consultation with surgical colleagues in the North-west Thames Area. From these patients are drawn cases for clinical trials of the value of hyperbaric oxygen in radiotherapy,2 where a special effort towards detailed follow-up study is made including a routine chest x-ray film every six months. Four of the eight patients reported here (see table) come from the 124 patients included in this group between January 1966 and December 1973. The other four cases were among those not suitable for the trials.
Details of patients

Discussion
Of all the patients included in the hyperbaric oxygen trials, 74% gave a history of smoking over five cigarettes a day for more than five years. All eight patients described here were men who gave a history of heavy cigarette smoking. There appears to be no special pattern of time relationship between the occurrence of the two tumours nor any evidence that the treatment of the first tumour had any influence on the appearance of the second.
So far we have not seen a patient treated for carcinoma of the lung subsequently developing carcinoma of the bladder. As a longer latent interval with regard to cigarette smoking has been suggested for bladder cancer than for lung cancer such cases might be expected.3 The number of patients surviving after treatment of lung cancer is similar to that after treatment for bladder cancer. This is because the greater frequency of lung cancer is compensated for by the better overall survival in bladder cancer. This can be illustrated by considering the cancer statistics for England and Wales.4 In the year 1970 registration of male cases totalled 23 797 for carcinoma of trachea, bronchus, and lung and 5197 for carcinoma of the bladder. The percentage of male patients registered in 1962 and 1963 surviving for five years was 4-5% for lung and 27-8% for bladder. We can therefore expect 846 "lung survivors" and 982 "bladder survivors." Despite this equality in numbers at risk the higher incidence of lung cancer would make it probable that only one case of bladder cancer would be detected in patients treated for lung cancer during a period when five cases of lung cancer would be found in those treated for bladder cancer.
The pathological evidence for the existence of separate primary tumours has been carefully examined in each case. The histological appearance of the tumours was distinctly different in six patients; in one case the lung carcinoma was diagnosed by cytological study of sputum but the oat cells seen were clearly different from those in the histological material from the bladder. In one case, however, the diagnosis of lung carcinoma rests upon the naked eye findings at necropsy, as unfortunately no material was taken for histology. One lung tumour was clearly an adenocarcinoma, a type more commonly observed in non-smokers.
The appearance of a solitary tumour in the lung of a patient who has been treated in the past for carcinoma of the bladder may not be a metastasis and may be due to a new primary carcinoma of the lung. This possibility should be considered and the patient treated accordingly if a new tumour is confirmed. Although the prognosis in carcinoma of the bronchus is not good, it remains better than that of metastasis from carcinoma of the bladder provided that adequate treatment is given. In clinical trials of the management of malignant disease it is important to recognise new primary tumours and their possible influence upon survival. The appearance in a single patient of more than one of the malignancies associated with cigarette smoking is further evidence of the hazard of this habit. We wish to thank the Medical Research Council for their continuing support (SD, MIS, and ML) and our colleagues in surgery and pathology in district hospitals in the North-west Thames Region.
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Canadian sheet dermatitis
During 1971-2 there was an epidemic of dermatitis in the Ottawa area of Canada caused by Wabasso polyester-cotton bed sheets.' We have seen several patients with a similar dermatitis over the past 18 months. All had used Wabasso bed sheets.
Present series
Since April 1975 we have seen nine patients with widespread dermatitis who had recently purchased cheap Canadian bed sheets. Three days to two weeks after starting to use the sheets they had developed severe itching and burning sensations, especially at night. When pillow-cases had also been purchased, redness of the ears and puffy eyelids were early complaints. In some cases several members of one family were affected, and in others one bed partner was spared.
Clinically the cases looked similar and were recognisably different from other forms of contact dermatitis from fabrics. The most characteristic feature was red follicular lesions, especially on the limbs. There was wide variation in the severity of the rashes, the most severely affected patients having large, continuous areas of redness and oedema (see figure) and swollen faces with puffy eyelids. The axillae and other skin folds were spared, and nightwear gave some protection. Patients had often been diagnosed as having drug eruptions, scabies, or toxic erythemas.
Wabasso bed sheets can often be recognised on sight or from the patient's description. They are brightly coloured, either uniformly or, more often, in large abstract or floral patterns employing several colours. Mauve, pink, blue, yellow, and green are the most common. The patient may remember that the packet the sheets were in was printed in French as well as English or was stamped "Made in Canada."
Patch tests with the patients' own sheets produced negative results in five out of eight cases tested, and there were no positive patch test results with formaldehyde. Only one patient reacted to a standard formaldehyde clothing resin patch test. Laundering the sheets helped in only one case, in which tolerance was reported after three washes. Once the patients stopped using the sheets the rash usually resolved in three to four weeks.
Comment
When patients approach us with suggestions about the cause of their ailments our response depends on our previous conditioning. In this instance an identical dermatitis had already been reported in Canada.1 2 The dermatitis first occurred shortly after a sheet manufacturing company changed its processing methods in the permanent-press resin treatment of polyester-cotton sheets from a slow cold process to a hot flash process.3 The offending agent was shown to be a fragmentation product of permanent-press resin polymer that was rendered unsta'ale in the presence of heat and moisture.2 !ol\z;-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~. ...... t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Follicular lesions on buttocks becoming confluent over back.
The epidemic in Canada halted when the company discontinued the implicated processing method. All our patients bought the sheets from street markets or similar outlets rather than from high-street stores. It would be interesting to know how sheets made unsaleable in Canada because they produce a dermatitis appear on sale in Britain and perhaps in other countries. Correct diagnosis of Canadian sheet dermatitis rests on the triad of its follicular, clinical appearance, its involvement of usually more than one member of the family, and the frequently negative results on patch testing with the offending sheets. Paroxysmal brain stem dysfunction as presenting feature of multiple sclerosis Paroxysmal disturbances are differentiated from other transient episodes in multiple sclerosis by their explosive, short-lived, repetitive occurrence and by their localisation to the brain stem or cervical cord.' They have been reported in this disease but not as the sole presenting feature.1-4 We have recently seen a patient whose paroxysmal attacks
